Literature DB >> 21730015

Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle.

Sergio Domínguez-López1, Ian Mahar, Francis Rodriguez Bambico, Benoit Labonté, Rafael Ochoa-Sánchez, Marco Leyton, Gabriella Gobbi.   

Abstract

Melatonin (MLT) and serotonin (5-HT) are two biosynthetically related compounds implicated in several common physiological functions and the etiology of mood disorders. How they interact, though, is not yet fully understood. In this study, single-unit extracellular recordings were used to monitor dorsal raphe nucleus (DR) 5-HT neuronal activity in anesthetized rats, under basal conditions (CTRL), in response to MLT administration, and after pinealectomy (PX) across the light-dark cycle. Under basal conditions, the number of spontaneously active 5-HT neurons and their firing rate were both significantly lower in the dark phase. In the light phase, administration of MLT at low doses (0.5-1 mg/kg, i.v.) decreased 5-HT firing activity. This inhibitory effect of MLT was completely blocked by the MT₁/MT₂ receptor antagonist luzindole, but not by the selective MT(2) receptor antagonist 4P-PDOT, the selective 5-HT(1A) receptor antagonist WAY100635, or by the α₂ adrenoceptor antagonist idazoxan. In the opposite experiment, PX increased 5-HT firing activity in the dark phase, and this was reversed by MLT administration (1 mg/kg, i.v.). Finally, in a forced swim test, MLT (1 mg/kg, i.p.) increased immobility time and decreased swimming behavior. Together, these results suggest that nocturnal MLT secretion imposes tonic inhibitory control over a sub-population of DR 5-HT neurons. This MLT-induced decrease in 5-HT neurotransmission may represent a biological mechanism underlying mood disorders characterized by increased MLT secretion, such as seasonal affective disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21730015     DOI: 10.1177/0269881111408460

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  7 in total

1.  Photoperiod programs dorsal raphe serotonergic neurons and affective behaviors.

Authors:  Noah H Green; Chad R Jackson; Hideki Iwamoto; Michael C Tackenberg; Douglas G McMahon
Journal:  Curr Biol       Date:  2015-05-07       Impact factor: 10.834

2.  Activation of Melatonin Receptors Reduces Relapse-Like Alcohol Consumption.

Authors:  Valentina Vengeliene; Hamid R Noori; Rainer Spanagel
Journal:  Neuropsychopharmacology       Date:  2015-05-21       Impact factor: 7.853

Review 3.  Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence.

Authors:  Pasquale Paribello; Mirko Manchia; Marta Bosia; Federica Pinna; Bernardo Carpiniello; Stefano Comai
Journal:  J Pineal Res       Date:  2022-03-10       Impact factor: 12.081

4.  Attenuation of morphine physical dependence and blood levels of cortisol by central and systemic administration of ramelteon in rat.

Authors:  Majid Motaghinejad; Ozra Motaghinejad; Pantea Hosseini
Journal:  Iran J Med Sci       Date:  2015-05

5.  Melatonin attenuates memory impairment induced by Klotho gene deficiency via interactive signaling between MT2 receptor, ERK, and Nrf2-related antioxidant potential.

Authors:  Eun-Joo Shin; Yoon Hee Chung; Hoang-Lan Thi Le; Ji Hoon Jeong; Duy-Khanh Dang; Yunsung Nam; Myung Bok Wie; Seung-Yeol Nah; Yo-Ichi Nabeshima; Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-30       Impact factor: 5.176

6.  Abnormal Hippocampal Melatoninergic System: A Potential Link between Absence Epilepsy and Depression-Like Behavior in WAG/Rij Rats?

Authors:  Slavianka Moyanova; Antonio De Fusco; Ines Santolini; Roberta Celli; Domenico Bucci; Federica Mastroiacovo; Giuseppe Battaglia; Ferdinando Nicoletti; Jane Tchekalarova
Journal:  Int J Mol Sci       Date:  2018-07-06       Impact factor: 5.923

Review 7.  The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.

Authors:  Domenico De Berardis; Stefano Marini; Michele Fornaro; Venkataramanujam Srinivasan; Felice Iasevoli; Carmine Tomasetti; Alessandro Valchera; Giampaolo Perna; Maria-Antonia Quera-Salva; Giovanni Martinotti; Massimo di Giannantonio
Journal:  Int J Mol Sci       Date:  2013-06-13       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.